Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Verorab Rabies Vaccine

Vaccine (Inactivated vaccine) · Immune activation, directed at rabies virus

Phase 1 Most advanced trial (none active)
1 Registered trials

What is Verorab Rabies Vaccine?

Verorab is a purified inactivated rabies vaccine prepared on Vero cells using the Wistar rabies PM/WI 38 1503-3M strain. It is supplied as a powder and solvent for suspension for injection in a prefilled syringe.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Vaccine (Inactivated vaccine)
Targets
rabies virus (antigen)
Mechanism
Immune activation, directed at rabies virus
Therapy area
Infectious disease
In trials of
NVAX
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05135273 Phase 1 Malaria,Falciparum Completed NVAX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Malaria,Falciparum

Sources

Updated Oct 3, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.